Boundless Bio BOLD Cash Flow Statement (2023-2026)

NASDAQ BOLD
$2.97 +0.07 (+2.48%)
As of: Aug 21, 2026 · 12:53 PM EDT
Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter) -12.39M-13.11M-13.90M-12.88M-50.32M-20.23M-16.64M-16.86M-15.86M-24.57M-85.43M-14.69M-81.63M-26.43M
Depreciation and Depletion (Quarter) 0.24M0.24M0.26M0.27M0.80M
Share-based Compensation (Quarter) 0.61M0.93M0.88M-2.14M1.33M2.13M2.04M2.01M1.80M1.69M10.70M1.33M1.37M3.22M
Asset Writedowns and Impairment (Quarter) 1.62M
Cash from Operations (Quarter) -20.95M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.12M0.70M1.28M1.21M0.97M1.70M1.33M1.05M0.82M0.69M0.58M0.51M0.33M0.17M
Depreciation & Amortization (CF) (Quarter) 0.20M0.20M0.21M0.25M0.26M0.30M0.26M0.30M0.32M0.32M0.31M0.31M0.28M1.26M
Change in Working Capital
Change in Accured Expenses (Quarter) 1.47M
Other Working Capital Changes (Quarter) -11.69M
Investing Activities
Capital Expenditures (Quarter) 0.04M
Change in Acquisitions & Divestments (Quarter) 31.50M
Cash from Investing Activities (Quarter) 23.07M
Financing Activities
Other financing activities (Quarter) 0.03M0.03M0.09M0.04M0.06M92.94M-92.94M0.02M
Change in Capital Stock
Shares Issued (Quarter) 5.95M
Net Equity Issued and Repurchased (Quarter) -0.33M
Misc.
Cash from Financing Activities (Quarter) 0.03M99.70M-0.45M-1.38M-0.92M90.65M-0.01M0.11M0.02M
Change in Cash (Quarter) 2.17M
Free Cash Flow (Quarter) -20.98M
Net Cash Flow (Quarter) 2.12M